Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke
Condition(s):Stroke, IschemicLast Updated:July 22, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Stroke, IschemicLast Updated:July 22, 2020Completed
Condition(s):Achievement of a Sufficient Thrombosis Prohpylaxis in Clitically Ill Patients With Heparin ResistanceLast Updated:November 17, 2017Completed
Condition(s):ARDS; COVID-19Last Updated:March 1, 2024Completed
Condition(s):CVDLast Updated:November 23, 2015Completed
Condition(s):Ischemic StrokeLast Updated:May 11, 2017Terminated
Condition(s):Ischemic StrokeLast Updated:November 10, 2014Completed
Condition(s):Heparin-induced ThrombocytopeniaLast Updated:December 8, 2022Terminated
Condition(s):Heparin-induced Thrombocytopenia Type IILast Updated:August 1, 2016Completed
Condition(s):Coronary Artery Bypass Graft Surgery; Presence of Heparin/Platelet Factor 4 AntibodyLast Updated:November 17, 2017Terminated
Condition(s):Heparin Induced Thrombocytopenia (HIT)Last Updated:June 21, 2012Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.